A vendor that markets a research peptide for human use, or makes health claims about it, steps outside research-use-only rules and can draw action from regulators like the FTC
These materials are sold for research purposes only and are not intended for human consumption
BPC-157 is a peptide originally discovered in gastric proteins and studied for its role in supporting tissue repair, cellular integrity, and the body's natural recovery processes
The peptide works through several distinct mechanisms that promote healing and tissue regeneration
Common (5-15% of users): Mild injection site reactions, minor digestive changes Uncommon (1-5%): Sleep changes, temporary fatigue, mild headache Rare (under 1%): Dizziness, flushing, mood changes Very Rare: Serious adverse effects rarely reported in community use Theoretical Concerns BPC-157s ability to stimulate angiogenesis (blood vessel formation) raises theoretical questions about its use in individuals with active cancer or high cancer risk
BPC-157, for tissue repair, is typically taken orally once daily or injected once or twice a day around injury sites